Home
About Us
Pipeline
The Rare Diseases
Partners and Collaborators
News
Contact Us
More
Triple Monoamine Reuptake Inhibitor for the treatment of hyperphagia in Prader-Willi Syndrome.
Advanced preclinical GlyT-1 inhibitor for the treatment of LID in Parkinson's disease.
MCHR1 antagonist for the treatment of rare neurological disorders.